Becton, Dickinson and Co. | BDX - Gross Profit On Sales

Stock Price
155.40
Daily Change
-1.69 -1.08%
Monthly
-5.17%
Yearly
-21.96%
Q2 Forecast
149.86

Becton, Dickinson and Co. reported $2.41B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Agilent USD 946M 44M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
AngioDynamics USD 44.78M 2.93M Sep/2025
Avanos Medical USD 86M 0 Dec/2025
Baxter International USD 577M 373M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
Cooper Companies USD 695.2M 44.4M Dec/2025
Danaher USD 3.97B 443M Dec/2025
Dentsply International USD 443M 2M Dec/2025
Dexcom USD 792.7M 61.3M Dec/2025
Edwards Lifesciences USD 1.23B 18.7M Dec/2025
Globus Medical USD 535.95M 49.28M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
Insulet USD 568.6M 58.5M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
J&J USD 16.6B 118M Dec/2025
Masimo USD 247.3M 16.7M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Solventum Corp USD 1.03B 108M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Terumo JPY 153.19B 6.2B Dec/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025